GlassScriptPhysician profile
Michael W Cluck
NPI 1447205984
$329,544.77
in general payments reported to CMS, 2019-2025
11 companies · $94K in 2025
The $94K reported for 2025 was more than what 92% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $11K · 2022: $58K · 2023: $58K · 2024: $78K · 2025: $94K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $229K · Food and Beverage: $466 · Debt Forgiveness: $368 · Consulting Fee: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $228,842.49 |
| Food and Beverage | $466.19 |
| Debt Forgiveness | $367.87 |
| Consulting Fee | $250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $229,404.48 | 2022-2025 | Mariner Mis, Physio-Stim, Mariner |
| Seaspine Orthopedics Corporation | $92,731.73 | 2019-2022 | |
| Providence Medical Technology, INC. | $4,940.37 | 2019-2020 | |
| Nuvasive, INC. | $1,580.68 | 2020-2022 | |
| Djo, LLC | $367.87 | 2023 | |
| Medtronic USA, INC. | $192.37 | 2019 | |
| Globus Medical, INC. | $142.16 | 2023 | Excelsiusgps Robotic Navigation System |
| Osseus Fusion Systems, LLC | $80.65 | 2020 | |
| Abbott Laboratories | $46.54 | 2022 | |
| Smith+Nephew, INC. | $29.42 | 2025 | Collagenase Santyl |
| Boston Scientific Corporation | $28.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cluck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.